Terms: = Prostate cancer AND SMARCE1, ENSG00000073584, 6605, BAF57, Q969G3
6 results:
1. Preoperative bullae and subsequent pneumothorax in 6605 patients who underwent robotic prostatectomy.
Yu J; Park JY; Lee J; Ha S; Hong JH; Kim YK
J Anesth; 2022 Dec; 36(6):740-746. PubMed ID: 36192651
[TBL] [Abstract] [Full Text] [Related]
2. baf57 Is a Potential Determinant of Colorectal cancer Malignancy.
Suzumura H; Tsuruta M; Okabayashi K; Shigeta K; Seishima R; Ishida T; Shimada T; Asada Y; Koishikawa K; Akimoto S; Itano O; Hasegawa H; Kitagawa Y
Anticancer Res; 2021 Nov; 41(11):5445-5452. PubMed ID: 34732413
[TBL] [Abstract] [Full Text] [Related]
3. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.
Alpsoy A; Dykhuizen EC
J Biol Chem; 2018 Mar; 293(11):3892-3903. PubMed ID: 29374058
[TBL] [Abstract] [Full Text] [Related]
4. Aberrant baf57 signaling facilitates prometastatic phenotypes.
Balasubramaniam S; Comstock CE; Ertel A; Jeong KW; Stallcup MR; Addya S; McCue PA; Ostrander WF; Augello MA; Knudsen KE
Clin Cancer Res; 2013 May; 19(10):2657-67. PubMed ID: 23493350
[TBL] [Abstract] [Full Text] [Related]
5. ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract.
Li X; Zhu C; Tu WH; Yang N; Qin H; Sun Z
PLoS One; 2011; 6(9):e25040. PubMed ID: 21949845
[TBL] [Abstract] [Full Text] [Related]
6. Targeting the baf57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
Link KA; Balasubramaniam S; Sharma A; Comstock CE; Godoy-Tundidor S; Powers N; Cao KH; Haelens A; Claessens F; Revelo MP; Knudsen KE
Cancer Res; 2008 Jun; 68(12):4551-8. PubMed ID: 18559499
[TBL] [Abstract] [Full Text] [Related]
